Protective Effects of L‐Arginine against Cisplatin‐Induced Renal Oxidative Stress and Toxicity: Role of Nitric Oxide

Basic and Clinical Pharmacology and Toxicology - Tập 97 Số 2 - Trang 91-97 - 2005
Samira Saleh1, Ebtehal El‐Demerdash2
1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, and
2Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Egypt

Tóm tắt

Abstract: Nephrotoxicity is a dose‐limiting factor in clinical use of cisplatin. The changes in renal haemodynamics were suggested to play a role in cisplatin‐induced nephrotoxicity. The aim of the present study was to investigate the effect of modulation of nitric oxide on the severity of cisplatin‐induced nephrotoxicity using an experimental rat model. A nitric oxide precursor, L‐arginine and an inhibitor of nitric oxide synthase, L‐NAME were used. After six days of cisplatin injection, acute nephrotoxicity was demonstrated by a marked increase in serum creatinine and blood urea nitrogen. Histological examination of the kidneys confirmed the occurrence of renal damage. Moreover, cisplatin induced an increase in the level of lipid peroxides and oxidized glutathione and a depletion of reduced glutathione. The activities of the antioxidant enzymes glutathione peroxidase and superoxide dismutase were also lowered. Besides, there was a reduction in the kidney total nitrate/nitrite levels. L‐arginine significantly attenuated the oxidative stress and nephrotoxic effect of cisplatin. On the other hand, L‐NAME was found to aggravate cisplatin nephrotoxicity. In conclusion, the decrease in the kidney nitric oxide level contributes, at least in part, in the mechanism underlying the nephrotoxicity of cisplatin. Furthermore, L‐arginine shows nephroprotective effects and might be useful in improving the therapeutic index of cisplatin.

Từ khóa


Tài liệu tham khảo

10.1038/ki.1995.213

10.1097/00007890-199711150-00002

10.1006/phrs.2000.0724

10.1016/S0270-9295(03)00089-5

10.1046/j.1523-1755.1998.00767.x

10.1016/S0014-2999(00)00025-X

Cernadas M. R., 1992, Renal and systemic effects of amino acids administered separately: comparison between L‐arginine and non‐nitric oxide donor amino acids, J. Pharm. Exp. Therap., 263, 1023

Ellman G. L., 1959, Tissue sulfhydryl groups, Arch. Biochem. Biophys., 74, 214

Fabinay D. L., 1971, Automated reaction rate method for determination of serum creatinine with the CentrifiChem, Clin. Chem., 17, 696, 10.1093/clinchem/17.8.696

Garnick M. B., 1988, Acute renal failure, 621

Garza‐Quintero R., 1993, Conversion of structure in ATP‐depleted proximal tubules: role of calcium, polyphosphoinositides and glycine, Amer. J. Physiol., 265, F605

10.1046/j.1523-1755.2002.00233.x

10.1590/S0100-879X2003000700017

10.1038/ki.1991.210

10.1097/01.ju.0000105073.67242.eb

10.1007/BF00686332

10.1093/ndt/12.12.2478

10.1016/0006-2952(94)90269-0

10.1093/jnci/81.10.724

10.1016/S0021-9258(19)52451-6

10.1006/phrs.2002.0968

Marklund S. L., 1985, Handbook of methods for oxygen radical research, 243

10.1006/niox.2000.0319

Mistry P., 1991, The effects of cisplatin on the concentration of protein thiols and glutathione in the rat kidney, Cancer Chemother. Pharmacol., 28, 277, 10.1007/BF00685535

Moncada S., 1991, Nitric oxide: physiology, pathophysiology and pharmacology, Pharmacol. Rev., 43, 109

10.1016/S1043-6618(03)00040-9

10.1007/BF00255906

10.1016/0003-2697(79)90738-3

10.1006/phrs.1999.0569

10.1042/bj0940705

Paglia D. E., 1967, Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase, J. Lab. Clin. Med., 70, 158

10.1038/333664a0

10.1021/ac50011a034

10.1159/000069714

10.1016/0006-2952(92)90725-X

10.1016/0003-2697(69)90064-5

10.1016/S0305-7372(97)90012-8

10.1038/ki.1991.58

Winston J. A., 1985, Reduced renal blood flow in early cisplatin‐induced acute renal failure in the rat, Amer. J. Physiol., 249, F490

10.1016/0006-2952(94)90383-2